Skip to main content

Peer Review reports

From: Clinical and economic impact of ‘ROS1-testing’ strategy compared to a ‘no-ROS1-testing’ strategy in advanced NSCLC in Spain

Original Submission
22 Nov 2021 Submitted Original manuscript
22 Dec 2021 Reviewed Reviewer Report - Laura Iadeluca
21 Jan 2022 Reviewed Reviewer Report - Adam C. Smith
14 Feb 2022 Author responded Author comments - David Carcedo
18 Feb 2022 Author responded Author comments - David Carcedo
Resubmission - Version 2
14 Feb 2022 Submitted Manuscript version 2
3 Mar 2022 Reviewed Reviewer Report - Adam C. Smith
7 Mar 2022 Reviewed Reviewer Report - Laura Iadeluca
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
8 Mar 2022 Editorially accepted
19 Mar 2022 Article published 10.1186/s12885-022-09397-4

You can find further information about peer review here.

Back to article page